Vigil Neuroscience Inc's Customers Performance

Name: Vigil Neuroscience Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

VIGL

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


VIGL's Source of Revenues		• List of VIGL Customers

for the same period Vigil Neuroscience Inc

• List of VIGL Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Vigil Neuroscience Inc's Comment on Sales, Marketing and Customers

News about Vigil Neuroscience Inc Contracts

Exploring New Frontiers Vigil Neuroscience Reveals Promising Data on Alzheimers Treatment Amidst Financial Challenges

In a groundbreaking development for those battling Alzheimer s disease, Vigil Neuroscience has unveiled promising preclinical and clinical data at the prestigious AD/PD 2025 International Conference regarding their innovative small molecule TREM2 agonist, VG-3927. While the company s financial ratios underwent scrutiny due to rising current liabilities, this promising medical advancement heralds a potential turning point in Alzheimer s treatment and sheds light on the company s strategic focus amidst fiscal challenges. Promising Preclinical InsightsDuring the conference, Vigil Neuroscience spotlighted the unique pharmacological blueprint of VG-3927. In their riveting preclinical presentation, researchers hig...

Unveiling the Clinical Overlap and Genetic Testing Challenges in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP): Insights from ACTRIMS 2024

Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) is a rare neurodegenerative disorder that presents with variable symptoms, often resembling multiple sclerosis (MS). Genetic testing plays a crucial role in definitive ALSP diagnosis, but patients encounter various barriers in accessing this essential tool. This article aims to explore the clinical overlap of ALSP and MS, while shedding light on the challenges faced by ALSP patients regarding genetic testing.Clinical Overlap of ALSP and MS:The recent American Committee for the Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 conference featured an insightful poster presentation by Dr. Vigil, focusing on the impacts of ...

VIGL's Stock Performance relative to it's Customers

VIGL's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Vigil Neuroscience Inc	383.34	0.00	-92.16	16
SUBTOTAL	0.00	0.00	0.00	-

Sources: Vigil Neuroscience Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Vigil Neuroscience Inc’s corporate clients.
For your research, we’ve provided 9 tables on Vigil Neuroscience Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.